Furthermore, the role of PAX5 in leukemogenesis is demonstrated by the identification of somatic PAX5 mutations in up to one-third of all B-ALL cases [89]. This evidence concerns the gene PAX5 and precursor B-cell acute lymphoblastic leukemia.